-
iTeos Therapeutics' (ITOS) "Outperform" Rating Reaffirmed at Wedbush
Источник: Buzz FX / 10 янв 2025 19:41:14 America/Chicago
iTeos Therapeutics' (ITOS) "Outperform" Rating Reaffirmed at Wedbush Written by MarketBeat January 10, 2025 Share Link copied to clipboard. iTeos Therapeutics ( NASDAQ:ITOS - Get Free Report ) 's stock had its "outperform" rating reiterated
Read more...